The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis Patients

NCT04195919 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemodialysis Patients

Interventions

DRUG: Evogliptin 5mg
DRUG: Evogliptin 5mg

Sponsor

Dong-A ST Co., Ltd.